# 99mTc-3PRGD2 SPECT/CT in Esophagus Cancer Patients

> **NCT02744729** · EARLY_PHASE1 · COMPLETED · sponsor: **First Affiliated Hospital of Fujian Medical University** · enrollment: 29 (actual)

## Conditions studied

- Esophageal Cancer

## Interventions

- **DRUG:** 99mTc-3PRGD2

## Key facts

- **NCT ID:** NCT02744729
- **Lead sponsor:** First Affiliated Hospital of Fujian Medical University
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-10
- **Primary completion:** 2017-01
- **Final completion:** 2017-01
- **Target enrollment:** 29 (ACTUAL)
- **Last updated:** 2020-08-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02744729

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02744729, "99mTc-3PRGD2 SPECT/CT in Esophagus Cancer Patients". Retrieved via AI Analytics 2026-05-23 from https://api.ai-analytics.org/clinical/NCT02744729. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*